Format

Send to

Choose Destination
Haematologica. 2017 Nov;102(11):e443-e446. doi: 10.3324/haematol.2017.170340. Epub 2017 Jul 27.

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

Author information

1
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy pbulian@cro.it.
2
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
3
Division of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
4
Division of Hematology, Ferrarotto Hospital, Catania, Italy.
5
Department of Hematology, Mayo Clinic, Rochester, MN, USA.
6
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
7
IRCCS, Referral Cancer Center of Basilicata, Potenza, Italy.
8
Oncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy.
9
Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
10
Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy.
11
Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
PMID:
28751560
PMCID:
PMC5664405
DOI:
10.3324/haematol.2017.170340
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center